Abstract

The multiplier method is one of the most frequently used population size estimation (PSE) methods for key populations, yet estimates from this method are often inconsistent with each other, other PSE methods and local knowledge. We developed a novel Bayesian approach, the 'Anchored Multiplier', which synthesizes estimates from multipliers coupled to an a priori estimate to arrive at a single consensus estimate and credible range. Data for size estimation were collected from three cross-sectional bio-behavioural surveillance studies of people who inject drugs (PWID) in San Francisco, CA, USA (2005, 2009 and 2012). We demonstrate the application of the Anchored Multiplier and a Variance Adjusted-Anchored Multiplier using PSE produced by multipliers in the three surveys and the literature for the USA. Size estimates were compared with estimates from other available PSE methods. Using the Anchored Multiplier, we estimated the PWID population made up 2.41% [95% credible interval (CI): 1.9-2.85] of the adult population in 2005, 2.1% (95% CI: 1.8-2.48) in 2009 and 2.3% (95% CI: 2.03-2.61) in 2012. The Variance Adjusted-Anchored Multiplier calculated similar point estimates, with wider 95% credible intervals. Credible intervals from both approaches were substantially narrower than from other standard PSE methods and, unlike other methods, indicated that the prevalence of PWID was stable over time. The Anchored Multiplier is a promising new approach to size estimation, which generates a single estimate to inform programmatic strategies to counter the HIV epidemic, and provides a robust denominator to quantify the burden of disease for key populations.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.